{"id":1664,"date":"2017-10-16T08:41:58","date_gmt":"2017-10-16T08:41:58","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=1664"},"modified":"2017-10-16T08:47:49","modified_gmt":"2017-10-16T08:47:49","slug":"insight-success-enyo-pharma-leveraging-viruses-to-develop-first-in-class-drug-candidates-in-many-indications","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/insight-success-enyo-pharma-leveraging-viruses-to-develop-first-in-class-drug-candidates-in-many-indications\/","title":{"rendered":"Insight Success &#8211; Â鶹Æƽâ°æ: Leveraging viruses to develop first-in-class drug candidates in many indications"},"content":{"rendered":"<p><a href=\"http:\/\/www.insightssuccess.com\/enyo-pharma-leveraging-viruses-to-develop-first-in-class-drug-candidates-in-many-indications\" target=\"_blank\">http:\/\/www.insightssuccess.com\/enyo-pharma-leveraging-viruses-to-develop-first-in-class-drug-candidates-in-many-indications<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><a href=\"http:\/\/www.insightssuccess.com\/enyo-pharma-leveraging-viruses-to-develop-first-in-class-drug-candidates-in-many-indications\" target=\"_blank\">http:\/\/www.insightssuccess.com\/enyo-pharma-leveraging-viruses-to-develop-first-in-class-drug-candidates-in-many-indications<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-1664","post","type-post","status-publish","format-standard","hentry","category-media-coverage-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/media-coverage-fr\/\" rel=\"category tag\">Couverture m\u00e9diatique<\/a>","rttpg_excerpt":"http:\/\/www.insightssuccess.com\/enyo-pharma-leveraging-viruses-to-develop-first-in-class-drug-candidates-in-many-indications","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=1664"}],"version-history":[{"count":2,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1664\/revisions"}],"predecessor-version":[{"id":1667,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1664\/revisions\/1667"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=1664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=1664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=1664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}